Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Crawford & Company B | CRD-B | Sep 27, 2024 | 11.07 | +0.18 |
Creative Media & Community Trust | CMCT | Sep 27, 2024 | 0.63 | -12.52 |
Creative Medical Technology | CELZ | Sep 27, 2024 | 2.98 | -1.32 |
Creative Realities | CREX | Sep 27, 2024 | 4.70 | -1.05 |
Credicorp | BAP | Sep 27, 2024 | 185.00 | +2.93 |
Credit Acceptance | CACC | Sep 27, 2024 | 447.69 | +1.43 |
Credit Enhanced Corts Trust Aon Capital A | KTN | Sep 27, 2024 | 26.91 | -0.33 |
Credit Suisse Ag | GLDI | Sep 27, 2024 | 155.58 | -0.19 |
Credit Suisse Ag | SLVO | Sep 27, 2024 | 80.28 | +0.14 |
Credit Suisse Asset Management Income Fund | CIK | Sep 27, 2024 | 3.08 | 0.00 |
Credit Suisse Gold Shares Covered Calls ETN | USOI | Sep 27, 2024 | 65.20 | +1.32 |
Credit Suisse High Yield Bond Fund | DHY | Sep 27, 2024 | 2.21 | 0.00 |
Credo Technology | CRDO | Sep 27, 2024 | 31.45 | +0.70 |
Crescent Capital BDC | CCAP | Sep 27, 2024 | 18.84 | +0.32 |
Crescent Energy | CRGY | Sep 27, 2024 | 11.13 | +3.34 |
Cresud A ADR | CRESY | Sep 27, 2024 | 9.08 | +0.89 |
Crexendo | CXDO | Sep 27, 2024 | 4.32 | -5.47 |
CRH | CRH | Sep 27, 2024 | 92.50 | -0.79 |
Cricut A | CRCT | Sep 27, 2024 | 6.88 | -0.72 |
Crinetics Pharmaceuticals | CRNX | Sep 27, 2024 | 50.75 | +0.34 |
CRISPR Therapeutics | CRSP | Sep 27, 2024 | 47.32 | +1.79 |
Criteo ADR | CRTO | Sep 27, 2024 | 40.54 | +3.66 |
Critical Metals | CRML | Sep 27, 2024 | 7.29 | +4.44 |
Crocs | CROX | Sep 27, 2024 | 144.31 | -2.10 |
Cronos Group | CRON | Sep 27, 2024 | 2.17 | -0.91 |
Cross Country Healthcare | CCRN | Sep 27, 2024 | 13.19 | -5.79 |
Cross Timbers Royalty Royalty Trust | CRT | Sep 27, 2024 | 10.23 | -1.45 |
CrossAmerica Partners LP Unit | CAPL | Sep 27, 2024 | 20.70 | +0.24 |
CrossFirst Bankshares | CFB | Sep 27, 2024 | 16.39 | -0.73 |
CrowdStrike A | CRWD | Sep 27, 2024 | 285.86 | +1.56 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.